Entinostat also known as SNDX-275 and MS-275 is a benzamide histone deacetylase inhibitor undergoing clinical trials for treatment of various cancers.Entinostat inhibits class I HDAC1 and HDAC3 with IC50 of 0.51 μM and 1.7 μM respectively.
This page contains content from the copyrighted Wikipedia article "Entinostat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
